BOSTON SCIENTIFIC CORPORATION Proceeds from Issuance of Long-term Debt and Capital Securities, Net
BOSTON SCIENTIFIC CORPORATION (BSX) reported Proceeds from Issuance of Long-term Debt and Capital Securities, Net of $1.68 billion for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet · last filed 2020-11-05
- BOSTON SCIENTIFIC CORPORATION proceeds from issuance of long-term debt and capital securities, net for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION proceeds from issuance of long-term debt and capital securities, net for the quarter ending 2020-06-30 was $1.68B.
- BOSTON SCIENTIFIC CORPORATION proceeds from issuance of long-term debt and capital securities, net for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION proceeds from issuance of long-term debt and capital securities, net for the quarter ending 2019-12-31 was $986.00M.
- BOSTON SCIENTIFIC CORPORATION proceeds from issuance of long-term debt and capital securities, net for fiscal 2019 was $7.23B, a 632.42% increase from fiscal 2018.
- BOSTON SCIENTIFIC CORPORATION proceeds from issuance of long-term debt and capital securities, net for fiscal 2018 was $987.00M.
- BOSTON SCIENTIFIC CORPORATION proceeds from issuance of long-term debt and capital securities, net for fiscal 2017 was $0.00.
- BOSTON SCIENTIFIC CORPORATION proceeds from issuance of long-term debt and capital securities, net for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
| Period end | Proceeds from Issuance of Long-term Debt and Capital Securities, Net 3 month | Proceeds from Issuance of Long-term Debt and Capital Securities, Net 6 month | Proceeds from Issuance of Long-term Debt and Capital Securities, Net 9 month | Proceeds from Issuance of Long-term Debt and Capital Securities, Net 12 month | Proceeds from Issuance of Long-term Debt and Capital Securities, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.68B derived: sum of 2 quarters · filed 2020-11-05 | $1.68B 10-Q · filed 2020-11-05 | $2.67B derived: sum of 4 quarters · filed 2020-11-05 | |
| 2020-06-30 | $1.68B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $1.68B 10-Q · filed 2020-08-05 | $2.67B derived: sum of 3 quarters · filed 2020-08-05 | $4.67B derived: sum of 4 quarters · filed 2020-11-05 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 | $986.00M derived: sum of 2 quarters · filed 2020-05-06 | $2.99B derived: sum of 3 quarters · filed 2020-11-05 | $2.99B derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-12-31 | $986.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $2.99B derived: sum of 2 quarters · filed 2020-11-05 | $2.99B derived: sum of 3 quarters · filed 2020-11-05 | $7.23B 10-K · filed 2020-02-25 | |
| 2019-09-30 | $2.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.00B derived: sum of 2 quarters · filed 2020-11-05 | $6.24B 10-Q · filed 2020-11-05 | $6.24B derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $4.24B 10-Q · filed 2020-08-05 | $4.24B derived: sum of 3 quarters · filed 2020-08-05 | $4.24B derived: sum of 4 quarters · filed 2020-08-05 | |
| 2019-03-31 | $4.24B 10-Q · filed 2020-05-06 | $4.24B derived: sum of 2 quarters · filed 2020-05-06 | $4.24B derived: sum of 3 quarters · filed 2020-05-06 | $4.24B derived: sum of 4 quarters · filed 2020-05-06 | |
| 2018-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$2.00M derived: sum of 2 quarters · filed 2020-02-25 | -$3.00M derived: sum of 3 quarters · filed 2020-02-25 | $987.00M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$1.00M derived: sum of 2 quarters · filed 2019-11-05 | $989.00M 10-Q · filed 2019-11-05 | $989.00M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $989.00M 10-Q · filed 2019-07-30 | $989.00M derived: sum of 3 quarters · filed 2020-02-25 | $989.00M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | $990.00M 10-Q · filed 2019-04-29 | $990.00M derived: sum of 2 quarters · filed 2020-02-25 | $990.00M derived: sum of 3 quarters · filed 2020-02-25 | $990.00M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $0.00 derived: sum of 2 quarters · filed 2018-10-29 | $0.00 10-Q · filed 2018-10-29 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $0.00 10-Q · filed 2018-07-31 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-01 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-19 | ||||
| 2015-12-31 | $2.54B 10-K · filed 2018-02-20 | $2.58B 10-K · filed 2016-02-24 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-23 | ||||
| 2013-12-31 | $1.44B 10-K · filed 2016-02-24 | ||||
| 2012-12-31 | $0.00 10-K · filed 2015-02-25 | ||||
| 2010-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2013-05-29 | $0.00 derived: sum of 2 quarters · filed 2013-05-29 | $973.00M 8-K · filed 2013-05-29 | ||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $973.00M 10-Q · filed 2011-11-08 | |||
| 2010-06-30 | $973.00M 10-Q · filed 2011-08-05 | ||||
| 2009-12-31 | $1.97B 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |